Cargando…

Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory

BACKGROUND: Next generation sequencing based tumor tissue genotyping involves complex workflow and a relatively longer turnaround time. Semiconductor based next generation platforms varied from low throughput Ion PGM to high throughput Ion Proton and Ion S5XL sequencer. In this study, we compared Io...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehrotra, Meenakshi, Duose, Dzifa Yawa, Singh, Rajesh R., Barkoh, Bedia A., Manekia, Jawad, Harmon, Michael A., Patel, Keyur P., Routbort, Mark J., Medeiros, L. Jeffrey, Wistuba, Ignacio I., Luthra, Rajyalakshmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540534/ https://www.ncbi.nlm.nih.gov/pubmed/28767674 http://dx.doi.org/10.1371/journal.pone.0181968

Ejemplares similares

Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors
por: Mehrotra, Meenakshi, et al.
Publicado: (2017)

Targeted Next-Generation Sequencing of Endometrial Cancer and Matched Circulating Tumor DNA: Identification of Plasma-Based, Tumor-Associated Mutations in Early Stage Patients
por: Bolivar, Ana M., et al.
Publicado: (2018)

Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours
por: Singh, R R, et al.
Publicado: (2014)

Clinical Assessment of PTEN Loss in Endometrial Carcinoma: Immunohistochemistry Out-Performs Gene Sequencing
por: Djordjevic, Bojana, et al.
Publicado: (2012)

Relationship between PTEN, DNA Mismatch Repair, and Tumor Histotype in Endometrial Carcinoma: Retained Positive Expression of PTEN Preferentially Identifies Sporadic Non-Endometrioid Carcinomas
por: Djordjevic, Bojana, et al.
Publicado: (2013)

Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing
por: Quesada, Andrés E., et al.
Publicado: (2018)

Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era
por: Montes-Moreno, Santiago, et al.
Publicado: (2018)

Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges
por: Luthra, Rajyalakshmi, et al.
Publicado: (2015)

Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ Malignancies
por: Chen, Hui, et al.
Publicado: (2015)

SDPS-44 RAPID DETECTION OF MUTATIONS IN CSF-CFTNA WITH THE GENEXUS INTEGRATED SEQUENCER
por: Arjuna, Srividya, et al.
Publicado: (2023)

Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing
por: Sabir, Sharjeel H., et al.
Publicado: (2017)

Clinical next generation sequencing to identify actionable aberrations in a phase I program
por: Boland, Genevieve M., et al.
Publicado: (2015)

Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray
por: Chen, Hui, et al.
Publicado: (2017)

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
por: Loghavi, Sanam, et al.
Publicado: (2014)

TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
por: Ok, Chi Young, et al.
Publicado: (2015)

Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures
por: Gouda, Mohamed A, et al.
Publicado: (2022)

RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD
por: Sakhdari, Ali, et al.
Publicado: (2019)

recoup: flexible and versatile signal visualization from next generation sequencing
por: Moulos, Panagiotis
Publicado: (2021)

P729: LANDSCAPE OF GERMLINE PATHOGENIC/ LIKELY PATHOGENIC MUTATIONS INVOLVING DNA REPAIR GENES IN SOLID TUMOR PATIENTS WITH ANTECEDENT OR SUBSEQUENT MYELOID NEOPLASMS
por: Hein, Kimberly, et al.
Publicado: (2023)

TELP, a sensitive and versatile library construction method for next-generation sequencing
por: Peng, Xu, et al.
Publicado: (2015)

Primary hemangioblastoma of the kidney with molecular analyses by next generation sequencing: a case report and review of the literature
por: Wang, Xintong, et al.
Publicado: (2022)

Concurrent Mutations in SF3B1 and PHF6 in Myeloid Neoplasms
por: Zuo, Zhuang, et al.
Publicado: (2022)

The Versatility of SMRT Sequencing
por: Hestand, Matthew S., et al.
Publicado: (2019)

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma
por: Siroy, Alan E., et al.
Publicado: (2014)

Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data
por: Dunn, Tamsen, et al.
Publicado: (2019)

Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS
por: Kanagal-Shamanna, Rashmi, et al.
Publicado: (2016)

VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
por: Lai, Zhongwu, et al.
Publicado: (2016)

BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer
por: Ramesh, Prashanthi, et al.
Publicado: (2021)

Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing
por: Gupta, Sanjeev Kumar, et al.
Publicado: (2020)

Multiplexed and Reiterative Fluorescence Labeling via DNA Circuitry
por: Duose, Dzifa Y., et al.
Publicado: (2010)

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
por: Ruiz-Cordero, Roberto, et al.
Publicado: (2020)

Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
por: Michikawa, Chieko, et al.
Publicado: (2022)

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
por: Bannon, Sarah A., et al.
Publicado: (2021)

XL odas /
por: Horacio
Publicado: (1946)

MathXL
por: Bittinger, Marvin L
Publicado: (2006)

DNAscan2: a versatile, scalable, and user-friendly analysis pipeline for human next-generation sequencing data
por: Marriott, Heather, et al.
Publicado: (2023)

Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation
por: Kanagal-Shamanna, Rashmi, et al.
Publicado: (2017)

XL odas selectas = XL Odae Selectae
por: Horacio
Publicado: (1946)

Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods
por: Yang, Richard K., et al.
Publicado: (2022)

Versatile Quality Control Methods for Nanopore Sequencing
por: Bolognini, Davide, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ri9kk29je3bebnitvajlcqd7li